JP2018501209A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501209A5 JP2018501209A5 JP2017527370A JP2017527370A JP2018501209A5 JP 2018501209 A5 JP2018501209 A5 JP 2018501209A5 JP 2017527370 A JP2017527370 A JP 2017527370A JP 2017527370 A JP2017527370 A JP 2017527370A JP 2018501209 A5 JP2018501209 A5 JP 2018501209A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- imidazol
- pyrrolo
- imidazo
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc(cc1)n[n]2c1nc(*)c2 Chemical compound Cc(cc1)n[n]2c1nc(*)c2 0.000 description 36
- LUYISICIYVKBTA-UHFFFAOYSA-N Cc(cc1)cc2c1nccc2 Chemical compound Cc(cc1)cc2c1nccc2 LUYISICIYVKBTA-UHFFFAOYSA-N 0.000 description 3
- NCRHHMSPXYGMIR-UHFFFAOYSA-N Cc1c[n]2ncnc2cc1 Chemical compound Cc1c[n]2ncnc2cc1 NCRHHMSPXYGMIR-UHFFFAOYSA-N 0.000 description 3
- DCUNRLLJHAWKRZ-UHFFFAOYSA-N Cc(cc1)cc2c1[nH]nc2 Chemical compound Cc(cc1)cc2c1[nH]nc2 DCUNRLLJHAWKRZ-UHFFFAOYSA-N 0.000 description 2
- HMMPHXCOTBASBC-UHFFFAOYSA-N Cc1cc([nH]nc2)c2cc1 Chemical compound Cc1cc([nH]nc2)c2cc1 HMMPHXCOTBASBC-UHFFFAOYSA-N 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462082959P | 2014-11-21 | 2014-11-21 | |
| US62/082,959 | 2014-11-21 | ||
| US201562141509P | 2015-04-01 | 2015-04-01 | |
| US62/141,509 | 2015-04-01 | ||
| PCT/US2015/060872 WO2016081364A1 (en) | 2014-11-21 | 2015-11-16 | Fused imidazole derivatives as tgf-beta inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018501209A JP2018501209A (ja) | 2018-01-18 |
| JP2018501209A5 true JP2018501209A5 (cg-RX-API-DMAC7.html) | 2018-12-27 |
| JP6789941B2 JP6789941B2 (ja) | 2020-11-25 |
Family
ID=54704137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017527370A Expired - Fee Related JP6789941B2 (ja) | 2014-11-21 | 2015-11-16 | Ｔｇｆ−ベータ阻害剤としての縮合イミダゾール誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10696693B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3221318B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6789941B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107207531B (cg-RX-API-DMAC7.html) |
| ES (1) | ES2895626T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016081364A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11040027B2 (en) | 2017-01-17 | 2021-06-22 | Heparegenix Gmbh | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| US11124509B2 (en) | 2017-03-23 | 2021-09-21 | Clavius Pharmaceuticals, LLC. | Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment |
| EP3840748A4 (en) * | 2018-08-22 | 2022-06-29 | Clavius Pharmaceuticals, LLC | Substituted imidazoles for the inhibition of tgf-beta and methods of treatment |
| CA3117710A1 (en) | 2018-12-11 | 2020-06-18 | Theravance Biopharma R&D Ip, Llc | Alk5 inhibitors |
| CA3160307A1 (en) | 2019-11-22 | 2021-05-27 | Theravance Biopharma R&D Ip, Llc | Substituted 1,5-naphthyridines or quinolines as alk5 inhibitors |
| CA3160368A1 (en) * | 2019-12-04 | 2021-06-10 | Henan Zhiwei Biomedicine Co., Ltd. | Substituted imidazolecarboxamide as bruton's tyrosine kinase inhibitors |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| WO2023208986A1 (en) | 2022-04-27 | 2023-11-02 | Chiesi Farmaceutici S.P.A. | Imidazole derivatives as alk5 inhibitors |
| US20250368650A1 (en) | 2022-06-22 | 2025-12-04 | Chiesi Farmaceutici S.P.A. | 5-(4-fluorophenyl)-2,3-dihydro-1h-imidazo[1,2-a]imidazole derivatives as alk inhibitors for the treatment of fibrosis |
| WO2024032598A1 (zh) * | 2022-08-08 | 2024-02-15 | 河南迈英诺医药科技有限公司 | TGF-β抑制剂化合物及其用途 |
| PL248267B1 (pl) * | 2023-04-13 | 2025-11-17 | Uniwersytet Medyczny W Lublinie | 1-arylo-6-hydroksyimino-5(1H)okso-2,3-dihydroimidazo[1,2-a] imidazole oraz sposób ich wytwarzania oraz ich zastosowanie |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60027135T2 (de) | 1999-01-21 | 2007-01-11 | Metamorphix, Inc. | Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen |
| PL348924A1 (en) * | 1999-11-10 | 2002-06-17 | Ortho Mcneil Pharm Inc | Substituted 2−aryl−3−(heteroaryl)−imidazo[1,2−a |
| US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
| AU2003256297A1 (en) | 2002-08-09 | 2004-02-25 | Eli Lilly And Company | Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| AU2003290734A1 (en) * | 2002-11-27 | 2004-06-23 | Eli Lilly And Company | Novel compounds as pharmaceutical agents |
| PA8595001A1 (es) * | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
| US20100166819A1 (en) * | 2005-12-22 | 2010-07-01 | Biogen Idec Ma Inc. A Corporation | Transforming Growth Factor Modulators |
| CA2665214A1 (en) * | 2006-10-06 | 2008-05-29 | Abbott Laboratories | Novel imidazothiazoles and imidazoxazoles |
| US8188083B2 (en) * | 2007-06-28 | 2012-05-29 | Abbott Laboratories | Triazolopyridazines |
| KR101938368B1 (ko) * | 2011-07-13 | 2019-01-14 | 주식회사 티움바이오 | Alk5 및/또는 alk4 억제제로서의 2-피리딜-치환된 이미다졸 |
| WO2014100533A1 (en) * | 2012-12-21 | 2014-06-26 | Bristol-Myers Squibb Company | NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 δ/ε INHIBITORS |
| WO2015087231A1 (en) * | 2013-12-11 | 2015-06-18 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
| US20150159134A1 (en) * | 2013-12-11 | 2015-06-11 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
-
2015
- 2015-11-16 CN CN201580074061.5A patent/CN107207531B/zh not_active Expired - Fee Related
- 2015-11-16 US US15/527,908 patent/US10696693B2/en active Active
- 2015-11-16 JP JP2017527370A patent/JP6789941B2/ja not_active Expired - Fee Related
- 2015-11-16 EP EP15801080.1A patent/EP3221318B1/en active Active
- 2015-11-16 WO PCT/US2015/060872 patent/WO2016081364A1/en not_active Ceased
- 2015-11-16 ES ES15801080T patent/ES2895626T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018501209A5 (cg-RX-API-DMAC7.html) | ||
| CN115956080B (zh) | 双环化合物，包含其的组合物及其应用 | |
| AU2016226468B2 (en) | TGF-beta inhibitors | |
| JP2018510857A5 (cg-RX-API-DMAC7.html) | ||
| KR102841843B1 (ko) | 트리아졸로-피리미딘 화합물 및 그의 용도 | |
| KR102007056B1 (ko) | 과증식성 질환 치료시 Bub1 키나제 저해제로 사용하기 위한 치환된 벤질인다졸 | |
| WO2022157629A1 (en) | Pharmaceutical combinations of sos1 inhibitors for treating and/or preventing cancer | |
| AU2019280356B2 (en) | ERK inhibitor and use thereof | |
| KR20180134983A (ko) | Ret 키나아제 억제제로서의 헤테로사이클릭 화합물 | |
| JP6789941B2 (ja) | Ｔｇｆ−ベータ阻害剤としての縮合イミダゾール誘導体 | |
| RU2019120986A (ru) | Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2 | |
| AU2019390863B2 (en) | Heterocyclic compound | |
| CA3198809A1 (en) | Heterocyclic spiro compounds and methods of use | |
| CA3107365A1 (en) | Pyrazine compounds and uses thereof | |
| AU2021370660A1 (en) | Heterocyclic spiro compounds and methods of use | |
| CN119768403A (zh) | 作为ddr抑制剂用于治疗纤维化病症和癌症的吡啶并吡唑类 | |
| CN114989173B (zh) | 咪唑类化合物、其药物组合物及其用途 | |
| WO2024068976A1 (en) | Azole derivatives as shp2 inhibitors | |
| CA3269027A1 (en) | Azole derivatives as shp2 inhibitors | |
| TWI624461B (zh) | 喹唑啉化合物，其製備方法及用途 | |
| CN119585263A (zh) | 苯基取代的二氢蔡咤类化合物及其制备与用途 | |
| RU2021118348A (ru) | Циклические тетрамерные соединения как ингибиторы пропротеин-конвертазы субтилизин/кексин типа 9 (pcsk9) для лечения метаболических нарушений |